Authors: Elizabeth Wager, Rahul Mhaskar, Stephanie Warburton, Benjamin Djulbegovic
DOI: 10.1371/journal.pone.0013591
Abstract Summary
JAMA’s 2005 policy requiring independent statistical analysis for industry-funded trials led to a significant drop in published industry-sponsored studies, while competitor journals saw increases. This suggests the policy deterred submissions or reduced acceptance rates, raising questions about balancing editorial rigor with access to industry research.
Why Brain? 🧠
JAMA’s 2005 policy requiring independent statistical analysis for industry-funded trials led to fewer such studies being published, suggesting pharmaceutical companies may avoid journals with stricter oversight requirements.
The image is AI-generated for illustrative purposes only. Courtesy of Midjourney.
